SARS-CoV-2 variants of concern elicit divergent early immune responses in hACE2 transgenic mice

被引:2
|
作者
Fricke, Charlie [1 ]
Pfaff, Florian [2 ]
Ulrich, Lorenz [2 ]
Halwe, Nico Joel [2 ]
Schoen, Jacob [2 ]
Timm, Laura [1 ]
Hoffmann, Weda [1 ]
Rauch, Susanne
Petsch, Benjamin [3 ]
Hoffmann, Donata [2 ]
Beer, Martin [2 ]
Corleis, Bjoern [1 ]
Dorhoi, Anca [1 ]
机构
[1] Friedrich Loeffler Inst, Inst Immunol, Greifswald, Germany
[2] Friedrich Loeffler Inst, Inst Diagnost Virol, Greifswald, Germany
[3] CureVac SE, Tubingen, Germany
关键词
K18-hACE2; SARS-CoV-2; variant of concern; immune response; compartmentalization; INFECTION; CELLS;
D O I
10.1002/eji.202250332
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
Knowledge about early immunity to SARS-CoV-2 variants of concern mainly comes from the analysis of human blood. Such data provide limited information about host responses at the site of infection and largely miss the initial events. To gain insights into compartmentalization and the early dynamics of host responses to different SARS-CoV-2 variants, we utilized human angiotensin converting enzyme 2 (hACE2) transgenic mice and tracked immune changes during the first days after infection by RNAseq, multiplex assays, and flow cytometry. Viral challenge infection led to divergent viral loads in the lungs, distinct inflammatory patterns, and innate immune cell accumulation in response to ancestral SARS-CoV-2, Beta (B.1.351) and Delta (B.1.617.2) variant of concern (VOC). Compared to other SARS-CoV-2 variants, infection with Beta (B.1.351) VOC spread promptly to the lungs, leading to increased inflammatory responses. SARS-CoV-2-specific antibodies and T cells developed within the first 7 days postinfection and were required to reduce viral spread and replication. Our studies show that VOCs differentially trigger transcriptional profiles and inflammation. This information contributes to the basic understanding of immune responses immediately postexposure to SARS-CoV-2 and is relevant for developing pan-VOC interventions including prophylactic vaccines. Fricke et al. report on early immune responses to various SARS-CoV-2 variants in the K18-hACE2 mouse. Beta triggers recruitment of neutrophils and monocytes, whereas Delta depletes alveolar macrophages. Spike-specific T and B cells mutually control virus dissemination and growth in this model. These insights inform the development of pan-variant interventions. (Created with BioRender.com)image
引用
收藏
页数:18
相关论文
共 50 条
  • [41] Stapled peptides as potential inhibitors of SARS-CoV-2 binding to the hACE2 receptor
    Tzotzos, Susan
    JOURNAL OF PEPTIDE SCIENCE, 2022, 28 (09)
  • [42] The Effects of ATIR Blocker on the Severity of COVID-19 in Hypertensive Inpatients and Virulence of SARS-CoV-2 in Hypertensive hACE2 Transgenic Mice
    Jiang, Xiaoliang
    Li, Huadong
    Liu, Yong
    Bao, Linlin
    Zhan, Lingjun
    Gao, Hong
    Deng, Wei
    Xue, Jing
    Liu, Jiangning
    Liu, Xing
    Li, Junli
    Wang, Jie
    Wu, Shuang
    Yan, Mingzhe
    Luo, Wei
    Jose, Pedro A.
    Qin, Chuan
    Yang, Xiuhong
    Zhang, Dingyu
    Yang, Zhiwei
    JOURNAL OF CARDIOVASCULAR TRANSLATIONAL RESEARCH, 2022, 15 (01) : 38 - 48
  • [43] Lipid Nanoparticle RBD-hFc mRNA Vaccine Protects hACE2 Transgenic Mice against a Lethal SARS-CoV-2 Infection
    Elia, Uri
    Rotem, Shahar
    Bar-Haim, Erez
    Ramishetti, Srinivas
    Naidu, Gonna Somu
    Gur, David
    Aftalion, Moshe
    Israeli, Ma'ayan
    Bercovich-Kinori, Adi
    Alcalay, Ron
    Makdasi, Efi
    Chitlaru, Theodor
    Rosenfeld, Ronit
    Israely, Tomer
    Melamed, Sharon
    Ionita, Inbal Abutbul
    Danino, Dganit
    Peer, Dan
    Cohen, Ofer
    NANO LETTERS, 2021, 21 (11) : 4774 - 4779
  • [44] Lethal synergy between SARS-CoV-2 and Streptococcus pneumoniae in hACE2 mice and protective efficacy of vaccination
    Barman, Tarani Kanta
    Singh, Amit K.
    Bonin, Jesse L.
    Nafiz, Tanvir Noor
    Salmon, Sharon L.
    Metzger, Dennis W.
    JCI INSIGHT, 2022, 7 (11)
  • [45] The evolution of the spike protein and hACE2 interface of SARS-CoV-2 omicron variants determined by hydrogen bond formation
    Yang, Yu-Yuan
    Tseng, Yufeng Jane
    BRIEFINGS IN FUNCTIONAL GENOMICS, 2023, 22 (03) : 291 - 301
  • [46] Comparative pathology of the nasal epithelium in K18-hACE2 Tg mice, hACE2 Tg mice, and hamsters infected with SARS-CoV-2
    Yu, Pin
    Deng, Wei
    Bao, Linlin
    Qu, Yajin
    Xu, Yanfeng
    Zhao, Wenjie
    Han, Yunlin
    Qin, Chuan
    VETERINARY PATHOLOGY, 2022, 59 (04) : 602 - 612
  • [47] Immune response to SARS-CoV-2 variants of concern in vaccinated individuals
    Becker, Matthias
    Dulovic, Alex
    Junker, Daniel
    Ruetalo, Natalia
    Kaiser, Philipp D.
    Pinilla, Yudi T.
    Heinzel, Constanze
    Haering, Julia
    Traenkle, Bjoern
    Wagner, Teresa R.
    Layer, Mirjam
    Mehrlaender, Martin
    Mirakaj, Valbona
    Held, Jana
    Planatscher, Hannes
    Schenke-Layland, Katja
    Krause, Gerard
    Strengert, Monika
    Bakchoul, Tamam
    Althaus, Karina
    Fendel, Rolf
    Kreidenweiss, Andrea
    Koeppen, Michael
    Rothbauer, Ulrich
    Schindler, Michael
    Schneiderhan-Marra, Nicole
    NATURE COMMUNICATIONS, 2021, 12 (01)
  • [48] Immune response to SARS-CoV-2 variants of concern in vaccinated individuals
    Matthias Becker
    Alex Dulovic
    Daniel Junker
    Natalia Ruetalo
    Philipp D. Kaiser
    Yudi T. Pinilla
    Constanze Heinzel
    Julia Haering
    Bjoern Traenkle
    Teresa R. Wagner
    Mirjam Layer
    Martin Mehrlaender
    Valbona Mirakaj
    Jana Held
    Hannes Planatscher
    Katja Schenke-Layland
    Gérard Krause
    Monika Strengert
    Tamam Bakchoul
    Karina Althaus
    Rolf Fendel
    Andrea Kreidenweiss
    Michael Koeppen
    Ulrich Rothbauer
    Michael Schindler
    Nicole Schneiderhan-Marra
    Nature Communications, 12
  • [49] The emerging SARS-CoV-2 variants of concern
    Sanyaolu, Adekunle
    Okorie, Chuku
    Marinkovic, Aleksandra
    Haider, Nafees
    Abbasi, Abu Fahad
    Jaferi, Urooj
    Prakash, Stephanie
    Balendra, Vyshnavy
    THERAPEUTIC ADVANCES IN INFECTIOUS DISEASE, 2021, 8
  • [50] The origin of SARS-CoV-2 variants of concern
    Burki, Talha
    LANCET INFECTIOUS DISEASES, 2022, 22 (02): : 174 - 175